Myriad Genetics |
Fecha/Hora | / |
Dif. / Dif.(%) | - / |
Bid | - |
Ask | - |
Apertura | - |
Cierre del día anterior | - |
Máxima sesión | - |
Mínima sesión | - |
Volumen [USD] | - |
Volumen [Unidades] | |
Fijación de precios | |
ISIN | US62855J1043 |
Símbolo | MYGN |
Bolsa | IEX |
Tipo | Acciones |
Otras Bolsas
Bolsa | Último | Volumen | |
---|---|---|---|
NASDAQ | 21,6200 | ![]() |
46.453 |
IEX | 21,63 | ![]() |
3.602 |
Cboe US | 21,55 | ![]() |
1.064 |
Hannover | 20,380 | ![]() |
0 |
Frankfurt | 20,3700 | ![]() |
0 |
Berlin | 20,400 | ![]() |
0 |
München | 20,380 | ![]() |
0 |
Hamburg | 20,380 | ![]() |
0 |
Düsseldorf | 20,530 | ![]() |
0 |
Lang & Schwa.. | 20,430 | ![]() |
|
Stuttgart | 20,480 | ![]() |
|
gettex | 20,570 | ![]() |
|
Quotrix | 20,4700 | ![]() |
|
TradeGate | 20,040 | 50 | |
Xetra | 20,080 | 0 | |
London Domes.. | 22,06 | 100 |
Noticias
- Myriad Genetics Advances Precision Oncology with New Precise™ Solutions, Combines Genetic Insights from Multiple Tests to Guide Treatment Decisions and Improve Patient Care
14.03.2022 / 12:05 - GlobeNewswire - Myriad Genetics Receives FDA Approval of BRACAnalysis® CDx as a Companion Diagnostic for Lynparza® in Early Breast Cancer
12.03.2022 / 01:05 - GlobeNewswire - Myriad Genetics Named to Fast Company’s Annual List of World’s Most Innovative Companies
08.03.2022 / 13:22 - GlobeNewswire - Myriad Genetics CEO Paul Diaz to Speak at 42nd Annual Cowen Health Care Conference
02.03.2022 / 22:30 - GlobeNewswire - Myriad Genetics Reports Fourth Quarter 2021 Results, Provides Updates on Product Performance and Growth Initiatives
24.02.2022 / 15:00 - GlobeNewswire
Haga un click en el
para activar "push" cotizaciónes.
